Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

2025 Event

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

Itiliti Health offers prior authorization solutions to health plans that bring transparency, interoperability, and automation to their prior authorization processes. Our enterprise-wide implementation at a major health plan has delivered millions in cost savings for the payer and inspired providers to ask other payers to implement our solution.   PA Checkpoint, is a prior authorization lookup solution that enables plans to meet the pending CMS mandate for prior authorization transparency; while offering plans the opportunity to save money today.  PA Complete provides payers prior authorization automation through an auditable AI approach that can be implemented across all medical policies to automate adjudication and save time for clinical reviewers when they are necessary.  Itiliti Health solutions are designed to contribute maximum value from day one. Come visit us in the Club Start Up area to learn more about how we save plans money and drive efficiency for all.

itiliti health, Inc - HLTH 2021 Sponsor

Israel Export Institute, supported by member firms, private sector bodies and the government of Israel, advances business relationships between Israeli exporters and overseas businesses and organizations. By providing a wide range of export-oriented services to Israeli companies and complementary services to the international business community, the Institute helps build successful joint ventures, strategic alliances and trade partnerships. The IEICI’s Medical Device &amp; Digital Health Sector is part of the Life Science Department which is the leader in business matching between the more than 1,500 companies in the Israeli life science industry and worldwide business partners at all levels. It has a proven ability to identify and match suitable potential business partners, organize one-on-one business meetings, and is a focal point for contacts with the government as well as with industry. The Israeli Medical Device &amp; Digital Health sector has more than 1,000 companies targeting various fields of medicine: Cardiology, Oncology, Neurology, Emergency Medicine, Rehabilitation, Ophthalmology, Gastrointestinal, Orthopedics and Sport Medicine, Women’s Health, Pain and Wound Management, Dermatology and Aesthetics.  Offers a variety of innovative medical solutions and technologies that answer today’s healthcare challenges. Discover Israel’s Medical Device &amp; Digital Health Industry with IEICI The Foreign Trade Administration at the Ministry of Economy and Industry is responsible for managing and directing the international trade policy of the State of Israel. The Administration’s main fields of activity include promoting trade and exports, initiating and maintaining trade agreements, attracting and facilitating foreign investments and initiating strategic cooperation with foreign companies. Together with the Administration’s team in Israel, we operate a network of more than 45 Economic and Trade Offices around the world, which serve as the operational arm of the Ministry in the global markets.

The Israel Export Institute - HLTH 2021 Sponsor

Iterative Scopes is fast becoming the leader in computational gastroenterology through its pioneering application of powerful, proprietary artificial intelligence tools to the practice of gastroenterology and drug development. It is taking a multi-tiered approach to tackling the challenges of endoscopic-driven disease management. The initial products and services offered by Iterative Scopes aim to identify and standardize relevant insights from endoscopic videos used for detection and monitoring of colorectal cancers and IBD. Longer term, the company is building predictive models that can augment clinical trial endpoints and individualized therapeutic selection processes, with the potential to create novel endpoints that are better predictors of therapeutic response and disease outcomes. Spun out of MIT in 2017, the team is based in Cambridge, Massachusetts.

Iterative Scopes - HLTH 2021 Sponsor